Product and Turnkey Solutions fitting to your needs

The world’s first clinically proven technology to optimize absorption of EPA and DHA.

Growing the space between food and pharma through dietary management using key nutrient formulation, our products and health solutions are developed by our dedicated team, targeting unmet needs.

BASF pioneered the Omega-3 pharma market by introducing, in 1994, Omacor^®/Lovaza^TM as the first prescription omega-3 drug with approval from the FDA/EU. We became world leaders in high-concentrate Omega-3 fatty acids for pharmaceuticals.

Our dedicated nutrition expert team transforms our capabilities and technologies into meaningful science-based consumer propositions. We serve customers in the markets of dietary supplements, health foods, clinical nutrition and baby food.

Based on our expertise, we can offer expert knowledge and ownership of the whole value-chain and a team that proactively support supply chain management and knowledge in coordination with our partners and customers.

Accelon^™ is a breakthrough omega-3 technology that significantly accelerates omega-3 absorption, so you get more omega-3 to where it’s needed.

BASF is a leading supplier of microencapsulated omega-3 powders for infant and maternal nutrition, food fortification, and dietary supplements.

Leveraging world leading expertise, BASF is supplying Maxomega™ EPA97 to serve the generic Epadel (ethyl icosapentate) market in Japan. 

BASF’s omega-3 oils have an exceptional sensory profile and superior purity. Our award-winning Omega Oil TG products provide consumers with the cleanest form of nutrients.

We offer generic omega-3-acid ethyl esters (K85EE), the reference standard for prescription omega-3-acid ethyl esters, as an Active Pharmaceutical Ingredient (API).

BASF’s omega-3 fish oils have an exceptional sensory profile and superior purity.